Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Nov;338(5):504-9.
doi: 10.1007/BF00179321.

Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres

Affiliations

Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres

J A Brock et al. Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov.

Abstract

1. The effects of bretylium and guanethidine on the nerve terminal impulse and transmitter release from sympathetic postganglionic nerve terminals in the guinea-pig vas deferens have been studied in vitro using focal extracellular recording. Excitatory junction currents (EJCs) were used as a measure of transmitter release. 2. Both bretylium and guanethidine altered the configuration of the nerve terminal impulse in a manner consistent with their being local anaesthetics. 3. Bretylium (1-3 microM) only completely inhibited transmitter release when impulse propagation in the sympathetic nerve terminal was blocked. 4. In contrast, guanethidine (1-10 microM) could block transmitter release with little effect on the configuration of the nerve terminal impulse. 5. The inhibitory effects of these agents on both the nerve terminal impulse and on transmitter release were reversed by the indirectly acting sympathomimetic agent, d-amphetamine (1-10 microM). 6. Using this technique the mechanisms of action of drugs known to modify the transmitter release in sympathetic nerve terminals can be more precisely determined.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Pharmacol. 1984 Apr 13;100(1):85-90 - PubMed
    1. Br J Pharmacol. 1986 Dec;89(4):647-59 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmakol. 1969;265(3):260-77 - PubMed
    1. Br J Clin Pharmacol. 1982 Jan;13(1):35-44 - PubMed
    1. Br J Pharmacol. 1970 Apr;38(4):776-91 - PubMed

Publication types